110 / 1345
➢
30 - 45% develop recurrences within 2 - 3 years Post Rx
➢
Response Evaluation :
Important Predictor for recurrence & survivals
➢
Local Disease :
Response and Detection of Early Local Recurrence
➢
Pelvic and / or Para-aortic Nodal Disease
➢
Other Sites of Distant Metastasis :
Lung, Mediastinal Nodes, Bone,
PET / PET-CT and Cancer Cervix
Post Therapy Surveillance